Recent studies demonstrate that NRF2 plays a crucial role in drug resistance of cancer stem cells [9,26] and is essential for preserving tumorigenicity and self-renewal in glioma stem cells and breast cancer stem cells [27,28]. Here, NFE2L2 is linked to glioma.